Epileptic seizures after autologous peripheral blood progenitor infusion in a patient treated with high-dose chemotherapy for myeloma

被引：23
|
作者：
Hequet, O [1 ]
Dumontet, C [1 ]
El Jaafari-Corbin, A [1 ]
Salles, G [1 ]
Espinouse, D [1 ]
Arnaud, P [1 ]
Thieblemont, C [1 ]
Bouafia, F [1 ]
Coiffier, B [1 ]
机构：
[1] Ctr Hosp Lyon Sud, Dept Hematol, F-69310 Pierre Benite, France
来源：
BONE MARROW TRANSPLANTATION | 2002年 / 29卷 / 06期
关键词：
D O I：
10.1038/sj.bmt.1703383
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
Bone Marrow Transplantation (2002) 29, 544. doi:10.1038/sj.bmt.1703383
引用
收藏
页码：544 / 544
页数：1
相关论文
共 50 条
  • [1] Epileptic seizures after autologous peripheral blood progenitor infusion in a patient treated with high-dose chemotherapy for myeloma
    O Hequet
    C Dumontet
    A El Jaafari-Corbin
    G Salles
    D Espinouse
    P Arnaud
    C Thieblemont
    F Bouafia
    B Coiffier
    Bone Marrow Transplantation, 2002, 29 : 544 - 544
  • [2] Contamination of autologous peripheral blood progenitor cell grafts predicts overall survival after high-dose chemotherapy in multiple myeloma
    H. G. Kopp
    S. Yildirim
    K. C. Weisel
    L. Kanz
    W. Vogel
    Journal of Cancer Research and Clinical Oncology, 2009, 135 : 637 - 642
  • [3] Contamination of autologous peripheral blood progenitor cell grafts predicts overall survival after high-dose chemotherapy in multiple myeloma
    Kopp, H. G.
    Yildirim, S.
    Weisel, K. C.
    Kanz, L.
    Vogel, W.
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2009, 135 (04) : 637 - 642
  • [4] Severe and long-lasting disruption of T-cell receptor diversity in human myeloma after high-dose chemotherapy and autologous peripheral blood progenitor cell infusion
    Mariani, S
    Coscia, M
    Even, J
    Peola, S
    Foglietta, M
    Boccadoro, M
    Sbaiz, L
    Restagno, G
    Pileri, A
    Massaia, H
    BRITISH JOURNAL OF HAEMATOLOGY, 2001, 113 (04) : 1051 - 1059
  • [5] High-dose chemotherapy and autologous peripheral blood progenitor cell transplant for the treatment of Hodgkin's disease
    Weaver, CH
    Schwartzberg, L
    Li, W
    Hazelton, B
    West, W
    BONE MARROW TRANSPLANTATION, 1996, 17 (05) : 715 - 721
  • [6] High-dose chemotherapy and autologous peripheral blood stem cell transplantation in high-risk multiple myeloma
    Murakami, H
    Fujii, H
    Inaba, T
    Shimazaki, C
    Okamoto, S
    Miwa, A
    Sawamura, M
    Abe, M
    Chou, T
    Asaoku, H
    Kitahara, Y
    Hayashi, K
    Kosaka, M
    Togawa, A
    Takatsuki, K
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2004, 73 (03) : 169 - 173
  • [7] Leukapheresis after high-dose chemotherapy and autologous peripheral blood progenitor cell transplantation: a novel approach to harvest a second autograft
    Schwella, N
    Braun, A
    Ahrens, N
    Rick, O
    Salama, A
    TRANSFUSION, 2003, 43 (02) : 259 - 264
  • [8] High-dose chemotherapy and autologous peripheral blood stem cell rescue in a patient with pleuropulmonary blastoma
    de Castro, CG
    de Almeida, SG
    Gregianin, LJ
    Loss, JF
    Rivero, LF
    Schwartsmann, G
    Brunetto, AL
    JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2003, 25 (01) : 78 - 81
  • [9] Autologous peripheral-blood progenitor-cell support following high-dose chemotherapy or chemoradiotherapy in patients with high-risk multiple myeloma
    Marit, G
    Faberes, C
    Pico, JL
    Boiron, JM
    Bourhis, JH
    Brault, P
    Bernard, P
    Foures, C
    ConyMakhoul, P
    Puntous, M
    Vezon, G
    Broustet, A
    Girault, D
    Reiffers, J
    JOURNAL OF CLINICAL ONCOLOGY, 1996, 14 (04) : 1306 - 1313
  • [10] High-dose therapy with peripheral blood progenitor cell transplantation in multiple myeloma
    Goldschmidt, H
    Hegenbart, U
    Wallmeier, M
    Hohaus, S
    Engenhart, R
    Wannenmacher, M
    Haas, R
    ANNALS OF ONCOLOGY, 1997, 8 (03) : 243 - 246
12345